Pump Prime Aprotinin Fails to Limit Proinflammatory Cytokine Release After Coronary Artery Bypass Surgery

By Wei Minxin   Kuukasjärvi Pekka   Laurikka Jari   Pehkonen Erkki   Kaukinen Seppo   Laine Seppo   Tarkka Matti  

Scandinavian Cardiovascular Journal, Vol. 35, Iss. 1, 2001-02 ,pp. : 50-54

Informa Healthcare

Access to resources Recommend Favorite

Mini-Dose Pump-Prime Aprotinin Inhibited Enhanced Fibrinolytic Activity and Reduced Blood Loss and Transfusion Requirements After Coronary Artery Bypass Surgery

By Kunt Alper   Darcin Osman   Aydin Salih   Demir Deniz   Selli Cuneyt   Andac Mehmet  

Journal of Thrombosis and Thrombolysis, Vol. 19, Iss. 3, 2005-06 ,pp. : 197-200

Springer Publishing Company

Access to resources Recommend Favorite

On-pump versus off-pump coronary artery bypass surgery: what is the status after ROOBY, DOORS, CORONARY and GOPCABE?

By Houlind Kim  

Future Cardiology, Vol. 9, Iss. 4, 2013-07 ,pp. : 569-579

Future Medicine

Access to resources Recommend Favorite

Effects of Aprotinin During Cardiopulmonary Bypass in Patients Treated with Acetylsalicylic Acid

By Ivert Torbjörn   Intonti Mario   Stain-Malmgren Rigmor   Dumitrescu Alexandra   Blombäck Margareta  

Scandinavian Cardiovascular Journal, Vol. 32, Iss. 5, 1998-11 ,pp. : 289-295

Informa Healthcare

Access to resources Recommend Favorite

Off–pump versus on–pump coronary artery bypass surgery: Comparison of 270 case–matched elderly patients

By Fritz Markus  

Zeitschrift für Kardiologie, Vol. 93, Iss. 8, 2004-08 ,pp. : 612-617

Springer Publishing Company

Access to resources Recommend Favorite